Alira Health announces it’s role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy
Alira Health is pleased to announce its role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund OMX.
Merieux Equity Partners is a global asset manager specialized the healthcare & nutrition sectors. Cell-Easy is a novel French pharmaceutical laboratory specialized in the development and manufacturing of novel cell therapies for preclinical and clinical studies. This fund raising aims at accelerating the company’s growth in France and internationally, by expanding Cell-Easy management team and strengthening the company’s commercial presence in key regions.
To read the press release on BusinessWire, click here.
For more information, contact Joris Pezzini.